Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only. HOSPIRA, INC., LAKE FOREST, IL 60045 USA. NDC: 0409-1162-02.
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot #: 38-515-DK, Expiry: 1 FEB 2016.
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Hospira Inc.
- Reason for Recall:
- Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only. HOSPIRA, INC., LAKE FOREST, IL 60045 USA. NDC: 0409-1162-02.
Product Codes/Lot Numbers:
Lot #: 38-515-DK, Expiry: 1 FEB 2016.
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-1216-2015
Related Recalls
Presence of Particulate Matter: human hair found within an internal sample syringe.
Hospira, Inc. is voluntarily recalling one lot of list 14699-28, Minibore Extension Set, 59 inch with Spin Lock Collar, Non-DEHP, identified above due to a confirmed customer report of an occlusion of solvent in the male luer lock. This occlusion has the potential to prevent the set from being primed for use and cause a delay in therapy.
Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.